Literature DB >> 19414262

Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en.

Takeshi Honda1, Shuku Kubo, Takeshi Masuda, Masami Arai, Yoshiyuki Kobayashi, Makoto Yamashita.   

Abstract

A series of ester prodrugs of 7-O-methyl derivative of Zanamivir (compound 3) was synthesized and their efficacy was evaluated in an influenza infected mice model by intranasal administration. Compound 7c (CS-8958), octanoyl ester prodrug of the C-9 alcohol of compound 3, was found to be much longer-acting than Zanamivir. Furthermore, the in vivo efficacies of compounds 12a, 12b, and 12c, the linear alkyl ester prodrug of the carboxylic acid, were comparable to that exerted by compound 7c.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414262     DOI: 10.1016/j.bmcl.2009.04.067

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Chemoenzymatic synthesis of sialosides containing C7-modified sialic acids and their application in sialidase substrate specificity studies.

Authors:  Zahra Khedri; Yanhong Li; Saddam Muthana; Musleh M Muthana; Ching-Wen Hsiao; Hai Yu; Xi Chen
Journal:  Carbohydr Res       Date:  2014-03-06       Impact factor: 2.104

Review 2.  Drugs in development for influenza.

Authors:  David A Boltz; Jerry R Aldridge; Robert G Webster; Elena A Govorkova
Journal:  Drugs       Date:  2010-07-30       Impact factor: 9.546

3.  A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase.

Authors:  Masahiko Hayakawa; Narihiro Toda; Nancy Carrillo; Natalie J Thornburg; James E Crowe; Carlos F Barbas
Journal:  Chembiochem       Date:  2012-09-10       Impact factor: 3.164

4.  Zanamivir conjugated to poly-L-glutamine is much more active against influenza viruses in mice and ferrets than the drug itself.

Authors:  Alisha K Weight; Jessica A Belser; Terrence M Tumpey; Jianzhu Chen; Alexander M Klibanov
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

5.  Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.

Authors:  Shuku Kubo; Takanori Tomozawa; Masayo Kakuta; Akane Tokumitsu; Makoto Yamashita
Journal:  Antimicrob Agents Chemother       Date:  2010-01-04       Impact factor: 5.191

6.  Origin of the inhibitory activity of 4-O-substituted sialic derivatives of human parainfluenza virus.

Authors:  Yuji Itoh; Ayumi Sando; Kiyoshi Ikeda; Takashi Suzuki; Hiroaki Tokiwa
Journal:  Glycoconj J       Date:  2012-05-13       Impact factor: 2.916

7.  Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.

Authors:  Maki Kiso; Kyoko Shinya; Masayuki Shimojima; Ryo Takano; Kei Takahashi; Hiroaki Katsura; Satoshi Kakugawa; Mai Thi Quynh Le; Makoto Yamashita; Yousuke Furuta; Makoto Ozawa; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

Review 8.  Development of miracle medicines from sialic acids.

Authors:  Haruo Ogura
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

9.  Synthesis of highly functionalized β-aminocyclopentanecarboxylate stereoisomers by reductive ring opening reaction of isoxazolines.

Authors:  Melinda Nonn; Loránd Kiss; Reijo Sillanpää; Ferenc Fülöp
Journal:  Beilstein J Org Chem       Date:  2012-01-17       Impact factor: 2.883

Review 10.  Therapeutics against influenza.

Authors:  Elena A Govorkova; Jonathan A McCullers
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.